Intensity Therapeutics Inc
(INTS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 12-2021 | |
| Operating Expenses | 1,254 | 0 | 1,768 | 1,930 | 0 |
| Operating Income | -1,254 | N/A | -1,768 | -1,930 | N/A |
| Interest Expense | 83 | 0 | 15 | 15 | 0 |
| Other Income | 1 | 0 | 8 | 17 | 0 |
| Pre-tax Income | -1,336 | 0 | -1,775 | -1,928 | 0 |
| Net Income Continuous | -1,336 | N/A | -1,775 | -1,928 | N/A |
| Net Income | $-1,336 | $N/A | $-1,775 | $-1,928 | $N/A |
| EPS Basic Total Ops | -0.39 | N/A | -0.52 | -0.57 | N/A |
| EPS Basic Continuous Ops | -0.39 | N/A | -0.52 | -0.57 | N/A |
| EPS Diluted Total Ops | -0.39 | N/A | -0.52 | -0.57 | N/A |
| EPS Diluted Continuous Ops | -0.39 | N/A | -0.52 | -0.57 | N/A |
| EBITDA(a) | $-1,141 | $N/A | $-1,723 | $-1,930 | $N/A |